ACE2 |
angiotensin-converting enzyme 2; |
CCHFV |
Crimean–Congo hemorrhagic fever virus; |
CHIKV |
Chikungunya virus; |
DENV |
Dengue virus; |
DTC |
dithiocarbamate; |
EAV |
equine arteritis virus; |
EBOV |
Ebola virus; |
EC50
|
effective statistically calculated concentration that induces a specific effect in 50% of experimental population under direct/specific conditions; |
FCoV |
feline coronavirus; |
FIP |
feline infectious peritonitis; |
FIPV |
feline infectious peritonitis virus; |
FMDV |
foot-and-mouth disease virus; |
HA |
hemagglutinin; |
HAV |
hepatitis A; |
HBsAg |
Hepatitis B surface antigen (HBsAg), |
HBeAg |
Hepatitis B antigen; |
HBV |
hepatitis B; |
HCQ |
hydroxychloroquine; |
HCV |
hepatitis C; |
HIF-1 |
hypoxia-inducible factor-1; |
HIV |
human immunodeficiency virus; |
HK |
hinokitol; |
HSV |
herpes simplex virus; |
IC50
|
inhibitory concentration: median value of inhibitor, where 50% of biological and biochemical function of organism inhibition is observed; |
JEV |
Japanese encephalitis virus; |
NiRAN |
nidovirus RdRp-associated nucleotidyltransferase; |
NTP |
nucleoside triphosphate; |
PDTC |
pyrrolidine dithiocarbamate; |
PRRSV |
porcine reproductive and respiratory syndrome virus; |
PT |
pyrithione; |
RdRp |
RNA-dependent RNA polymerase; |
SARS-CoV |
respiratory syndrome coronavirus; |
SOD |
superoxide dismutase-1; |
UPS |
ubiquitin-proteasome system; |
ZIKV |
Zika virus |